Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Treatment of diabetic ketoacidosis in children and adolescents Vanelli M; Chiarelli FActa Biomed 2003[Aug]; 74 (2): 59-68Diabetic ketoacidosis (DKA) may be defined as a metabolic derangement characterized by hyperglycemia, acidosis and ketonuria. It is a crucial pediatric medical emergency. DKA may occur in children with diabetes at onset due to severe insulin deficiency, in established patients from failing to take insulin, acute stress, and poor sick-day management. The treatment of DKA has undergone a radical transformation over recent years. Among the major innovations the early adjustment of the hydroelectrolyte imbalance and the continuous i.v. infusion of microdoses of insulin are the most interesting. Despite appropriate use of insulin and fluids, and continuous clinical observation, the mortality rate has not improved, and has remained the same as that reported in the 1970s. DKA can be prevented by shortening the period of carbohydrate intolerance that usually precedes the diagnosis of Type 1 diabetes. Its prevention decreases morbidity and mortality and allows to save on the hospital costs. The aim of this paper is to review the main aspects of the treatment and prevention of DKA.|Adolescent[MESH]|Age Factors[MESH]|Brain Edema/diagnosis/etiology[MESH]|Child[MESH]|Diabetes Mellitus, Type 1/diagnosis/therapy[MESH]|Diabetic Ketoacidosis/complications/diagnosis/mortality/*therapy[MESH]|Emergencies[MESH]|Fluid Therapy[MESH]|Humans[MESH]|Infusions, Intravenous[MESH]|Insulin/administration & dosage/therapeutic use[MESH]|Monitoring, Physiologic[MESH]|Risk Factors[MESH]|Time Factors[MESH] |
